SWX/BMY (SWX/BMY)

SIX Swiss Exchange: SWX/BMY · CHF

CHF 51.4

+0.00 (0.0%)· Recorded snapshot

Market cap	105.5B
Revenue (ttm)	41.7B
Net income (ttm)	7.7B
EPS (ttm)	CHF 3.69
P/E (trailing)	13.9x
P/E (forward)	9.8x
Dividend	CHF 2.03 (3.95%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 41.7B
Net income (ttm): 7.7B
EPS (ttm): CHF 3.69
P/E (trailing): 13.9x
P/E (forward): 9.8x
Market cap: 105.5B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-03 14:30 UTC

Forward P/E9.8

P25 n/aP50 n/aP75 n/a

Trailing P/E13.9

P25 n/aP50 n/aP75 n/a

ROE44

P25 n/aP50 n/aP75 n/a

ROIC23.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SWX/BMY indicators

Market & fundamental data

Available fields

239

Groups with data

Currency

USD

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CHF
Country	United States
Country code	CH
Earnings date	2026-10-29
Employees	32,500
Employees change	-1,600
Employees growth	-4.69%
Enterprise value	CHF 131.6B
Exchange	SIX Swiss Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-07-12
Fiscal year end	December
Founded	1887
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	US1101221083
Last earnings date	2026-10-29
Last refreshed	2026-11-03
Market cap	CHF 105.5B
Next earnings date	2027-02-04
Price	CHF 51.42
Price currency	CHF
Sector	Healthcare
SIC code	2834
Stock price date	2026-11-02
Symbol	swx/BMY
Website	https://www.bms.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	38.04x
Average P/E ratio (3Y)	16.1x
Average P/E ratio (5Y)	18.6x
Earnings yield	7.18%
EV/Earnings	17.07x
EV/EBIT	9.89x
EV/EBITDA	8.63x
EV/FCF	16.99x
EV/Sales	3.21x
FCF / EV yield	5.89%
FCF yield	7.34%
Forward P/E	9.77x
Graham number	28.36029
Graham upside	-44.85%
Lynch fair value	CHF 18.79
Lynch upside	-63.46%
P/(FCF - SBC) ratio	14.48x
P/(OCF - SBC) ratio	12.52x
P/B ratio	5.4x
P/E ratio	13.93x
P/FCF ratio	13.62x
P/OCF ratio	11.87x
P/S ratio	2.53x
Price/EBITDA ratio	6.93x
Sector forward P/E	19.76x
Sector P/E	34.12x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	32.36%
EBITDA margin	36.46%
Effective tax rate	18.44%
FCF margin	18.93%
Gross margin	70.5%
Operating margin	32.36%
Pretax margin	22.65%
Profit margin	18.47%
Profit per employee	CHF 237,286
Profitable quarters	10
Profitable years	1
Revenue per employee	CHF 1.3M
ROA	10.9%
ROA (5Y)	6.51%
ROCE	23.13%
ROE	44.01%
ROE (5Y)	13.18%
ROIC	23.6%
ROIC (5Y)	14.63%
SBC / revenue	1.1%
Tax / revenue	4.18%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	51.93%
EPS growth (Q)	-2.78%
EPS growth (QoQ)	-35.19%
EPS growth 10Y	8.48%
EPS growth 3Y	4.61%
EPS growth years	1
FCF growth	-39.32%
FCF growth (Q)	-35.95%
FCF growth (QoQ)	24.26%
FCF growth 3Y	-7.38%
FCF growth 5Y	-8.61%
Gross profit growth	0.4%
Gross profit growth (Q)	0.29%
Gross profit growth 3Y	0.64%
Gross profit growth 5Y	-0.54%
Net income growth	53.06%
Net income growth (Q)	-1.77%
Net income growth (QoQ)	-34.82%
Net income growth 3Y	3.71%
Net income growth quarters	5
Net income growth years	1
OCF growth	-35.91%
OCF growth (Q)	-33.75%
OCF growth (QoQ)	23.22%
OCF growth 10Y	16.95%
OCF growth 3Y	-6.22%
OCF growth 5Y	-7.23%
Operating income growth	13.06%
Operating income growth (Q)	14.46%
Operating income growth 3Y	24.1%
Operating income growth 5Y	12.46%
Revenue growth	4.16%
Revenue growth (Q)	6.93%
Revenue growth (QoQ)	0.74%
Revenue growth 10Y	10.48%
Revenue growth 3Y	3.65%
Revenue growth 5Y	1.93%
Revenue growth quarters	5
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CHF -1.1B
Depreciation and amortization	CHF 1.7B
EBIT	CHF 13.5B
EBITDA	CHF 15.2B
EPS	CHF 3.69
Financing cash flow	CHF -9.5B
Free cash flow	CHF 7.7B
Free cash flow minus SBC	CHF 7.3B
Gross profit	CHF 29.4B
Income taxes	CHF 1.7B
Investing cash flow	CHF -4.4B
Net borrowing	CHF -5.1B
Net cash flow	CHF -5.1B
Net income	CHF 7.7B
Operating cash flow minus SBC	CHF 8.4B
Operating income	CHF 13.5B
Revenue	CHF 41.7B
Stock-based compensation	CHF 460.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.71
Book value per share	CHF 9.55
Debt / EBITDA	2.41
Debt / equity	1.91
Debt / FCF	4.83
Goodwill	CHF 17.8B
Interest coverage	9.87
Long-term assets	CHF 49.7B
Long-term liabilities	CHF 39.2B
Net cash (debt)	CHF -26.6B
Net cash / market cap	-25.18%
Net debt / EBITDA	1.75
Net debt / equity	1.36
Net debt / FCF	3.43
Piotroski F-Score	7
Property, plant and equipment	CHF 7.7B
Shareholders' equity	CHF 19.5B
Tangible book value	CHF -12.7B
Tangible book value per share	CHF -6.23
Total assets	CHF 74.1B
Total cash	CHF 10.5B
Total debt	CHF 37.4B
Total liabilities	CHF 54.5B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.54
Current assets	CHF 24.3B
Current liabilities	CHF 15.3B
Current ratio	1.59
Inventory turnover	5.4
Net working capital	CHF -266.2M
Quick ratio	1.36
Working capital	CHF 9.2B
Working capital turnover	4.51

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.48%
Dividend growth	-2.52%
Dividend growth (10Y)	3.13%
Dividend growth (3Y)	-0.76%
Dividend growth (5Y)	2.39%
Dividend growth years	0
Dividend payment date	2026-11-02
Dividend payment years	13
Dividend payout frequency	Quarterly
Dividend per share	CHF 2.03
Dividend yield	3.95%
Ex-dividend date	2026-10-02
Last dividend	CHF 0.52
Payout ratio	55.38%
Shareholder yield	3.47%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	2.94%
10Y return CAGR	4.03%
10Y total return	48.44%
150-day SMA	CHF 48.69
1D price change	0%
1M price change	0.08%
1M total return	1.11%
1W price change	1.1%
1W total return	1.1%
20-day SMA	CHF 50.01
200-day SMA	CHF 47.97
3M price change	-1.34%
3M total return	-0.33%
3Y price change	-5.2%
3Y return CAGR	2.28%
3Y total return	7.01%
50-day SMA	CHF 51.57
50-day SMA vs 200-day SMA	50over200
52-week high	CHF 54.34
52-week high date	2026-09-07
52-week low	CHF 42.54
52-week low date	2026-01-30
5Y price change	15.84%
5Y return CAGR	7.13%
5Y total return	41.13%
6M price change	10.39%
6M total return	12.78%
All-time high	CHF 74.80
All-time high date	2016-07-14
All-time low	CHF 42.54
All-time low date	2026-01-27
Average true range (ATR)	CHF 0.62
Average volume	0
Change from 52-week high	-5.37%
Change from 52-week low	20.87%
Change from all-time high	-31.26%
Change from all-time low	20.87%
Monthly RSI	51.56
Previous close	CHF 51.42
Price vs 150-day SMA	5.6%
Price vs 20-day SMA	2.82%
Price vs 200-day SMA	7.19%
Price vs 50-day SMA	-0.29%
Relative volume	20
RSI	54.51
Sharpe ratio	0.17
Sharpe ratio (3Y)	0.09
Sharpe ratio (5Y)	0.34
Sortino ratio	0.4
Sortino ratio (3Y)	0.45
Sortino ratio (5Y)	1.01
Weekly RSI	55.66
YTD price change	19.86%
YTD total return	25.19%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2B
Shares change (QoQ)	0.24%
Shares change (YoY)	0.48%
Shares held by insiders	0.05%
Shares held by institutions	82.93%
Short ratio	4.3 days

Deeper analysis on SWX/BMY

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SWX/BMY report

Is a complete SWX/BMY research report available?

No complete published report is available for swx/BMY (SWX/BMY) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SWX/BMY (SWX/BMY)

Price

Financial snapshot

Fair-value bridge

Latest news · SWX/BMY

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SWX/BMY indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SWX/BMY

Frequently asked questions